0001127602-15-004636.txt : 20150205
0001127602-15-004636.hdr.sgml : 20150205
20150205185657
ACCESSION NUMBER: 0001127602-15-004636
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150204
FILED AS OF DATE: 20150205
DATE AS OF CHANGE: 20150205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROTHBLATT MARTINE A
CENTRAL INDEX KEY: 0001106578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 15581572
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-02-04
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001106578
ROTHBLATT MARTINE A
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
1
1
Chairman & Co-CEO
Common Stock
2015-02-04
4
M
0
2211
63.22
A
2351
D
Common Stock
2015-02-04
4
S
0
611
139.9838
D
1740
D
Common Stock
2015-02-04
4
S
0
1500
140.8171
D
240
D
Common Stock
2015-02-05
4
M
0
5547
30.75
A
5787
D
Common Stock
2015-02-05
4
S
0
3610
140.844
D
2177
D
Common Stock
2015-02-05
4
S
0
1637
141.4872
D
540
D
Common Stock
2015-02-05
4
M
0
4115
34.56
A
4355
D
Common Stock
2015-02-05
4
S
0
4050
141.2729
D
305
D
Common Stock
2015-02-05
4
S
0
300
142.39
D
240
D
Common Stock
2015-02-05
4
S
0
65
141.2782
D
240
D
Common Stock
166
I
By Spouse
Common Stock
533094.05
I
By Trusts
Stock Options
63.22
2015-02-04
4
M
0
2211
0
D
2010-12-31
2020-12-31
Common Stock
2211
448852
D
Stock Options
30.75
2015-02-05
4
M
0
5547
0
D
2009-12-26
2017-12-31
Common Stock
5547
549118
D
Stock Options
34.56
2015-02-05
4
M
0
4115
0
D
2005-12-30
2015-12-30
Common Stock
4115
168730
D
This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
This transaction was executed in multiple trades at prices ranging from $139.67 to $140.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $140.30 to $141.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
This transaction was executed in multiple trades at prices ranging from $140.21 to $141.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $141.21 to $141.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $140.5701 to $141.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $142.25 to $142.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ John S. Hess, Jr. under Power of Attorney
2015-02-05